dihexa also known as pnb-0408 human trial Dihexa (also PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the dihexa pnb-0408 c-met hgfr activator
dihexa pnb 0408 c met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa Dihexa (PNB 0408) Dosing, Side Effects, FDA Status & Research PeptIQ PeptIQ Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted dihexa neuroplasticity dihexa chemical properties solubility stability dihexa stability in solution Dihexa (PNB 0408)
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

